Wayne Kuznar

Articles

Dupilumab tames AD in difficult-to-treat patients

November 14th 2017

Dupilumab given concomitantly with topical corticosteroids significantly improved signs and symptoms of atopic dermatitis (AD) in adults refractory to or intolerant of cyclosporine A, a study shows.

Latest Updated Articles

Published: September 19th 2024 | Updated: September 26th 2024

Final Thoughts: The Importance of Comparative Studies in AD

Published: November 17th 2023 | Updated: April 2nd 2025

POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?

Published: November 7th 2023 | Updated: April 2nd 2025

POLL: Which of the Following 2023 NP & PA Conferences Has Been Your Favorite?

Published: March 11th 2025 | Updated: April 2nd 2025

Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters

Published: March 15th 2025 | Updated: April 2nd 2025

Apoptosis-Based Skin Cancer Treatment Shows Promise

Published: March 7th 2025 | Updated: April 2nd 2025

Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health

Recent Content

Guselkumab Shows Strong Response in Long-Term Subtype Psoriasis Study

New Data on the Perception of Pregnancy-Related Skin Changes

Daily Derm Times: April 1, 2025

Melinda Gooderham, MD, MSc, FRCPC: Reaffirming Delgocitinib Safety With Minimal Absorption, Maximum Confidence

View More Recent Content

About

Advertise

Job Board

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777